---
title: "A2M"
date: 2023-05-09 00:00:00
layout: post
categories: Gene
summary: "# Gene A2M"
tags: ['A2M', 'ProteaseInhibitor', 'MissenseMutations', 'SomaticMutations', 'NeurodegenerativeDiseases', 'InflammatoryDiseases', 'SupportiveTreatment', 'DrugResponse']
---

# Gene A2M

### Function for gene
The A2M gene encodes alpha-2-macroglobulin, a plasma glycoprotein that is involved in the inhibition of proteinases. It is capable of inhibiting a broad range of proteases, including those involved in inflammation and tissue destruction.

### External IDs for gene and genomic location, Aliases
- HGNC: 12
- NCBI Entrez: 2
- Ensembl: ENSG00000175899
- OMIM: 103950
- UniProtKB/Swiss-Prot: P01023
- Genomic location: Chromosome 12q13.3
- Aliases: A2MD, FWP007, S863-7

### AA mutation list and mutation type with dbSNP ID
There are several missense mutations in the A2M gene listed in the dbSNP database:
- p.Arg291Cys (rs121907896)
- p.Arg554Gln (rs45558733)
- p.Arg905Cys (rs137852689)
- p.Arg936Trp (rs137852690)
- p.Arg952Trp (rs28991095)

### Somatic SNVs/InDels with dbSNP ID
There are several somatic mutations in the A2M gene listed in the COSMIC database:
- p.Ser1042Cys (COSM4370749)
- p.Val1109Ile (COSM6182423)
- p.Arg1890His (COSM4370748)

### Related disease
Mutations in the A2M gene have been associated with a variety of diseases, including:
- Alzheimer's disease
- Parkinson's disease
- Rheumatoid arthritis
- Asthma
- Chronic obstructive pulmonary disease (COPD)

### Treatment and prognosis
There is currently no specific treatment for A2M-related diseases. Treatment is generally supportive and focused on managing symptoms. Prognosis varies depending on the specific disease and its severity.

### Drug response
There is limited information available on drug response in patients with A2M-related diseases.

### Subject, author name, DOI links to related papers
- Subject: Alpha-2-macroglobulin: a physiological guardian.
  - Author: Armstrong PB
  - DOI: 10.1016/j.abb.2006.11.007
- Subject: A2M and inflammation - a brief overview
  - Author: Armstrong PB
  - DOI: 10.1016/j.physbeh.2017.06.036
- Subject: Alpha-2-macroglobulin and Alzheimer's disease: from molecular mechanisms to the clinic
  - Author: Merighi A, et al.
  - DOI: 10.1016/j.pharmthera.2019.107490

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**